Evidence map›Paper›PMID 33105932›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2020

[Aldo-keto reductase family 1 B10 participates in the regulation of hepatoma cell cycle through p27/p-Rb signaling pathway].

N Geng, Y Y Jin, S X Zhu, Y R Li, L Y Zheng, W J Zhu, Y W Li, C Han, X G Dou, H Bai

Open access · greenAbstract read
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

N GengDepartment of Infectious Disease, Shengjing Hospital of China Medical University, Shenyang 110022, China.
Y Y JinDepartment of Infectious Disease, Shengjing Hospital of China Medical University, Shenyang 110022, China.
S X ZhuDepartment of Infectious Disease, Shengjing Hospital of China Medical University, Shenyang 110022, China.
Y R LiDepartment of Infectious Disease, Shengjing Hospital of China Medical University, Shenyang 110022, China.
L Y ZhengDepartment of Infectious Disease, Shengjing Hospital of China Medical University, Shenyang 110022, China.
W J ZhuDepartment of Infectious Disease, Shengjing Hospital of China Medical University, Shenyang 110022, China.
Y W LiDepartment of Infectious Disease, Shengjing Hospital of China Medical University, Shenyang 110022, China.
C HanDepartment of Infectious Disease, Shengjing Hospital of China Medical University, Shenyang 110022, China.
X G DouDepartment of Infectious Disease, Shengjing Hospital of China Medical University, Shenyang 110022, China.
H BaiDepartment of Infectious Disease, Shengjing Hospital of China Medical University, Shenyang 110022, China.
China Medical University · CN

Funding

Liaoning Provincial Science and Technology Planning Project 2013225021"Thirteenth Five-Year Plan" Major National Science and Technology Major Projects 2017ZXl0202203-008
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell CycleSignal TransductionAldo-Keto ReductasesCarcinoma, HepatocellularCell Cycle CheckpointsCyclin-Dependent Kinase Inhibitor p27Gene SilencingHep G2 CellsHumansLiver NeoplasmsRetinoblastoma ProteinAKR1B10 protein, humanAldo-Keto ReductasesCDKN1B protein, humanCyclin-Dependent Kinase Inhibitor p27Retinoblastoma ProteinAldo keto reductase1B10Cell cycle arrestEpalrestatHepatocellular carcinomashRNA

Identifiers

PMID33105932
PMCPMC12770702
OpenAlexW3094531657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.